OncoMed - Skyrocker!!

 

https://www.finanzen.net/nachricht/aktien/...artalsergebnisse-6012622  

https://www.benzinga.com/news/earnings-previews/...earnings-a-preview

Kurs

https://www.nasdaq.com/de/symbol/omed/real-time  

 

 

https://www.streetinsider.com/Corporate+News//...2C+CEO/13957920.html  

https://m.nasdaq.com/de/symbol/omed/real-time  

https://www.nasdaq.com/de/symbol/omed/real-time  

lohnt es sich hier noch einzusteigen?  

kann aber gerne so weiter laufen, dann bin ich auch ohne Nachkauf wieder grün :)

https://www.nasdaq.com/de/symbol/omed/real-time  

bin auch noch dabei.  

 

 

fast Nullnummer? Wenn es unter 2,7 fällt bin ich weg.  

Gut das mein Stop am 18.9 gerissen wurde. Glück gehabt!

http://www.oncomed.com/invest/releasedetail.cfm?ReleaseID=1077128

 

Ob das Glück war ich bin noch dabei.  

Hätte bei 2$ noch mal schnappen sollen.    

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

http://www.oncomed.com/invest/releasedetail.cfm?ReleaseID=1079501

Gehe auch wieder rein! ;-))

 

https://www.fiercebiotech.com/biotech/...loses-oncomed-reverse-merger  

StockMarketWire.com - Mereo BioPharma Group said its proposed acquisition of OncoMed Pharmaceuticals had now received backing from 21.1% of the target's shareholders.

OncoMed said it had received support for the deal from Biotechnology Value Fund, Biotechnology Value Fund II, MSI BVF SPV and Biotechnology Value Trading Fund OS L.P. which represented about 10.45% of OncoMed's shares.

The backing adds to support announced by other investors in December.

Mereo BioPharma said it continued to make good progress towards closing the deal, which expects to occur in the second quarter of 2019.


http://www.stockmarketwire.com/article/6349803/...s-more-support.html  

OncoMed Pharmaceuticals erklärt Sonderdividende für bedingte Wertrechte
Von GlobeNewswire,  15. März 2019, 07:00:00 Uhr EDT  

http://www.lse.co.uk/AllNews.asp?code=bgt7me56